Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.
作者信息
Ahmadi-Simab K, Lamprecht P, Nölle B, Ai M, Gross W L
出版信息
Ann Rheum Dis. 2005 Jul;64(7):1087-8. doi: 10.1136/ard.2004.027128.
Abstract
摘要
相似文献
1
Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.利妥昔单抗成功治疗原发性干燥综合征难治性前巩膜炎。
Ann Rheum Dis. 2005 Jul;64(7):1087-8. doi: 10.1136/ard.2004.027128.
2
[B-cell depletion and primary Sjögren's syndrome: is there a role for rituximab?].[B细胞耗竭与原发性干燥综合征：利妥昔单抗有作用吗？]
Reumatismo. 2010 Apr-Jun;62(2):87-8. doi: 10.4081/reumatismo.2010.87.
3
[Is rituximab a promising treatment for Sjögren's syndrome?].[利妥昔单抗是干燥综合征的一种有前景的治疗方法吗？]
Rev Med Interne. 2008 Dec;29(12):967-70. doi: 10.1016/j.revmed.2008.02.022. Epub 2008 Apr 9.
4
Rituximab therapy in primary Sjögren's syndrome.利妥昔单抗治疗原发性干燥综合征。
Ann N Y Acad Sci. 2009 Sep;1173:701-5. doi: 10.1111/j.1749-6632.2009.04639.x.
5
Anti-CD20 antibody in primary Sjögren's syndrome management.抗CD20抗体在原发性干燥综合征治疗中的应用
Curr Pharm Biotechnol. 2014;15(6):535-41. doi: 10.2174/138920101506140910150431.
6
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.贝鲁单抗序贯利妥昔单抗治疗伴有 B 细胞淋巴增生和 BAFF 过表达的干燥综合征：长期疗效的证据。
Clin Exp Rheumatol. 2014 Jul-Aug;32(4):490-4. Epub 2014 May 7.
7
Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment.利妥昔单抗治疗原发性干燥综合征：长期随访、再次治疗的安全性和疗效
Ann Rheum Dis. 2009 Feb;68(2):284-5. doi: 10.1136/ard.2008.092601.
8
[First experience with the application of rituximab for the treatment of patients with Sjogren's syndrome and disease].利妥昔单抗应用于干燥综合征患者治疗的首次经验及疾病情况
Vestn Ross Akad Med Nauk. 2009(2):3-10.
9
Anti-CD20 treatment in primary Sjögren's syndrome.原发性干燥综合征的抗CD20治疗。
Scand J Immunol. 2008 Dec;68(6):554-64. doi: 10.1111/j.1365-3083.2008.02185.x. Epub 2008 Oct 23.
10
Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?抗 CD20 治疗（利妥昔单抗）治疗原发性干燥综合征。可行的方法还是仅仅是一个起点？
Expert Opin Biol Ther. 2011 Oct;11(10):1381-94. doi: 10.1517/14712598.2011.605352. Epub 2011 Aug 7.
引用本文的文献
1
Primary Sjögren's syndrome complicated by renal tubular acidosis and acute bilateral uveitis: a case report and literature review.原发性干燥综合征并发肾小管酸中毒和急性双侧葡萄膜炎：病例报告及文献复习。
J Int Med Res. 2024 Nov;52(11):3000605241275880. doi: 10.1177/03000605241275880.
2
Rituximab in the Treatment of Non-Infectious Uveitis: A Review.利妥昔单抗治疗非感染性葡萄膜炎：综述
J Inflamm Res. 2024 Sep 29;17:6765-6780. doi: 10.2147/JIR.S477708. eCollection 2024.
3
Sjögren's Versus Non-Sjögren's Ocular Features: Similar Symptoms, But Significantly Worse Signs.干燥综合征与非干燥综合征的眼部特征：相似的症状，但明显更严重的体征。
Invest Ophthalmol Vis Sci. 2024 Jan 2;65(1):23. doi: 10.1167/iovs.65.1.23.
4
A Review of Systemic Biologics and Local Immunosuppressive Medications in Uveitis.葡萄膜炎全身生物制剂和局部免疫抑制药物综述
J Ophthalmic Vis Res. 2022 Apr 29;17(2):276-289. doi: 10.18502/jovr.v17i2.10804. eCollection 2022 Apr-Jun.
5
Associations between Sjögren Syndrome, Sociodemographic Factors, Comorbid Conditions, and Scleritis in a Taiwanese Population-Based Study.一项基于台湾人群的研究：干燥综合征、社会人口学因素、合并症与巩膜炎之间的关联
J Pers Med. 2022 Jan 14;12(1):105. doi: 10.3390/jpm12010105.
6
Rituximab Therapy for Primary Sjögren's Syndrome.利妥昔单抗治疗原发性干燥综合征
Front Pharmacol. 2021 Sep 2;12:731122. doi: 10.3389/fphar.2021.731122. eCollection 2021.
7
Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.用于治疗非感染性巩膜炎的生物疗法和小分子药物：一项叙述性综述
Ophthalmol Ther. 2021 Dec;10(4):777-813. doi: 10.1007/s40123-021-00393-8. Epub 2021 Sep 2.
8
Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease.利妥昔单抗用于治疗非感染性非恶性眼眶炎性疾病。
J Ophthalmic Inflamm Infect. 2021 Aug 27;11(1):24. doi: 10.1186/s12348-021-00253-3.
9
Rituximab for non-infectious Uveitis and Scleritis.利妥昔单抗用于非感染性葡萄膜炎和巩膜炎。
J Ophthalmic Inflamm Infect. 2021 Aug 16;11(1):23. doi: 10.1186/s12348-021-00252-4.
10
Health system wide "big data" analysis of rheumatologic conditions and scleritis.对风湿性疾病和巩膜炎进行全卫生系统范围的“大数据”分析。
BMC Ophthalmol. 2021 Jan 6;21(1):14. doi: 10.1186/s12886-020-01769-3.
Zotero 插件